Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CAREDX, INC. (CDNA)

  • Business News
  • April 20, 2026, 11:05 UTC
  • 3
  • 1 comments

CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing

Market reaction Comment Full text

METROPOLITAN BANK HOLDING CORP. (MCB)

  • Business News
  • April 20, 2026, 11:05 UTC
  • 3
  • 1 comments

Metropolitan Commercial Bank Expands Florida Presence, Adds Jessica Raffo as Director of Association Banking

Market reaction Comment Full text

KRAIG BIOCRAFT LABORATORIES, INC. (KBLB)

  • Business News
  • April 20, 2026, 11:05 UTC
  • 3
  • 1 comments

Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons

Market reaction Comment Full text

GILAT SATELLITE NETWORKS LTD (GILT)

  • Business News
  • April 20, 2026, 11:02 UTC
  • 3
  • 1 comments

Gilat to Report First Quarter 2026 Results on Wednesday, May 13th

Market reaction Comment Full text

Passage Bio Inc (PASG)

  • Business News
  • April 20, 2026, 11:01 UTC
  • 4
  • 1 comments

Passage Bio, Inc. - Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates

Market reaction Comment Full text

Pasithea Therapeutics Corp. (KTTAW)

  • Business News
  • April 20, 2026, 11:01 UTC
  • 5
  • 1 comments

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

Market reaction Comment Full text

INVIVYD, INC. (IVVD)

  • Business News
  • April 20, 2026, 11:01 UTC
  • 4
  • 1 comments

Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit

Market reaction Comment Full text

PASITHEA THERAPEUTICS CORP. (KTTA)

  • Business News
  • April 20, 2026, 11:01 UTC
  • 7
  • 1 comments

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

Market reaction Comment Full text

GILAT SATELLITE NETWORKS LTD. (GILT)

  • Business News
  • April 20, 2026, 11:00 UTC
  • 3
  • 1 comments

Gilat to Report First Quarter 2026 Results on Wednesday, May 13th,2026

Market reaction Comment Full text

BNB PLUS CORP. (BNBX)

  • Business News
  • April 20, 2026, 11:00 UTC
  • 3
  • 1 comments

BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value

Market reaction Comment Full text
  • Previous
  • 1136
  • 1137
  • 1138
  • 1139
  • 1140
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158476)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin